Allergy Asthma Respir Dis.
2023 Oct;11(4):165-166. 10.4168/aard.2023.11.4.165.
Macrolide resistant Mycoplasma pneumonia: where we come from, where we are, and where do we go from here?
- Affiliations
-
- 1Department of Pediatrics, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea
- KMID: 2547446
- DOI: http://doi.org/10.4168/aard.2023.11.4.165
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Comparison of the characteristics of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae pneumonia requiring hospitalization in children
- The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma Pneumonia in Children
- Clinical issues regarding increased macrolide-resistant Mycoplasma pneumoniae in children
- Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children
- Related factors for and changes in clinical manifestations in mycoplasma pneumonia nonresponsive to macrolide treatment
